IL3RA identified as novel biomarker and therapeutic target for ER+ breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis.
Saved in:
| Title: | IL3RA identified as novel biomarker and therapeutic target for ER+ breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis. |
|---|---|
| Authors: | Mei H; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China.; Graduate School, Beijing University of Chinese Medicine, Beijing, China., Zhang Z; School of traditional Chinese medicine, Beijing University of Chinese Medicine, Beijing, China., Jiang N; Graduate School, Beijing University of Chinese Medicine, Beijing, China., Lu W; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China. lu_wenping@sina.com., Chang L; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China., Song Q; Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China., Li F; School of traditional Chinese medicine, Beijing University of Chinese Medicine, Beijing, China. lifeng_bucm0610@126.com. |
| Source: | Clinical proteomics [Clin Proteomics] 2026 Mar 05; Vol. 23 (1). Date of Electronic Publication: 2026 Mar 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101184586 Publication Model: Electronic Cited Medium: Print ISSN: 1542-6416 (Print) Linking ISSN: 15426416 NLM ISO Abbreviation: Clin Proteomics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
